Valuation: Embracing Future Holdings Limited

Market Cap 57.2M 44.96M 38.57M 36.02M 33.04M 62.14M 4.3B 63.16M 425M 166M 2.16B 169M 165M 7.13B P/E 2024
-8.18x
P/E 2025 -22.5x
Enterprise Value 59.06M 46.42M 39.82M 37.18M 34.12M 64.15M 4.44B 65.21M 439M 172M 2.23B 174M 171M 7.36B EV / Sales 2024
58.8x
EV / Sales 2025 17.5x
Free-Float
44.94%
Yield 2024 *
-
Yield 2025 -
1 week-15.38%
Current month-5.71%
1 month-17.50%
3 months-26.67%
6 months-54.17%
Current year-36.54%
1 week 0.03
Extreme 0.032
0.04
1 month 0.03
Extreme 0.032
0.04
Current year 0.03
Extreme 0.032
0.09
1 year 0.02
Extreme 0.021
0.09
3 years 0.01
Extreme 0.008
0.09
5 years 0.01
Extreme 0.008
0.26
10 years 0.01
Extreme 0.008
0.88
Manager TitleAgeSince
President 46 30/04/2024
Comptroller/Controller/Auditor 44 01/07/2024
Corporate Secretary - -
Director TitleAgeSince
Director/Board Member 64 14/06/2021
Director/Board Member 55 31/03/2023
Director/Board Member 70 27/11/2023
Date Insider Type Main position Quantity % Market Cap.
4/30/21 A Fiscal year

Chairman

330,000 0.1250%
8/19/20 A Free

Chairman

1,130,000 0.4340%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-15.38%+50.00%+120.00% 44.74M
+4.53%+1.99%+23.43%+15.55% 218B
+5.94%+2.69%-0.41%-15.53% 140B
+2.37%-0.20%-16.43%+39.69% 138B
+3.74%+1.70%-49.60%+3.72% 73.14B
+1.55%-0.81%+16.93%+20.92% 52.44B
+1.32%+2.43%-16.15%-12.09% 50.85B
+4.42%+4.67%+29.19%+30.55% 41.92B
+3.97%+0.64%+40.68%+56.77% 39.42B
+2.66%+3.27%+0.91%+8.22% 32.81B
Average +3.01%-1.77%+7.85%+26.78% 78.69B
Weighted average by Cap. +3.78%-2.40%+2.63%+14.28%

Financials

2024 2025
Net sales 858K 674K 579K 540K 496K 932K 64.46M 947K 6.37M 2.5M 32.33M 2.53M 2.48M 107M 5.26M 4.14M 3.55M 3.31M 3.04M 5.71M 395M 5.81M 39.08M 15.3M 198M 15.53M 15.19M 655M
Net income -3.43M -2.7M -2.32M -2.16M -1.98M -3.73M -258M -3.79M -25.51M -9.99M -129M -10.14M -9.91M -428M -3.96M -3.11M -2.67M -2.49M -2.29M -4.3M -298M -4.37M -29.43M -11.53M -149M -11.69M -11.44M -494M
Net Debt 1.46M 1.14M 981K 916K 840K 1.58M 109M 1.61M 10.81M 4.23M 54.82M 4.29M 4.2M 181M 1.86M 1.46M 1.25M 1.17M 1.07M 2.02M 139M 2.05M 13.79M 5.4M 69.93M 5.48M 5.36M 231M
Logo Embracing Future Holdings Limited
Biolidics Limited is a Singapore-based precision medicine medical technology company. The Company's principal activities are technology development, technology transfer, selling and distribution of biomedical technology, life and medicine science related products and services; provision of laboratory services and investment holding. Its segments are Cancer, Infectious diseases, and Laboratory services, and Corporate segments. Its Cancer and infectious diseases segments involve the identifying and assessing potential collaboration partners, technology, products and services, product development, innovation and improvement and the management of global distributorship networks and direct customers in the cancer field, and the infectious diseases field. The Laboratory services segment involves the business, operation, and provision of laboratory services to customers. The laboratory has regulatory approval from Singapore’s Ministry of Health for testing for COVID-19 in Singapore.
Employees
-
Date Price Change Volume
19/08/26 SGD 0.0330 0.00% 13,000
18/08/26 SGD 0.0330 -2.94% 453,700
17/08/26 SGD 0.0340 -2.86% 446,200
14/08/26 SGD 0.0350 +2.94% 200,000
13/08/26 SGD 0.0340 -12.82% 600